Literature DB >> 11369863

The HoxB1 hexapeptide is a prefolded domain: implications for the Pbx1/Hox interaction.

C M Slupsky1, D B Sykes, G L Gay, B D Sykes.   

Abstract

Hox proteins are transcriptional regulators that bind consensus DNA sequences. The DNA-binding specificity of many of these Hox proteins is modulated by the heterodimerization with partners, such as the Pbx proteins. This cooperative heterodimerization is accomplished through a conserved hexapeptide motif found N-terminal to the Hox DNA-binding homeodomain. Several human leukemias have been associated with a chromosomal translocation involving either the Hox gene (i.e., NUP98/HOXA9) or the gene encoding Pbx1 (E2A/PBX1). The transforming ability of these fusion oncoproteins relies at least partially on the ability to interact with one another through this hexapeptide motif. Herein we describe NMR structural calculations of the hexapeptide of HoxB1 (Nalpha-acetyl-Thr-Phe-Asp-Trp-Met-Lys-amide) that has been shown to mediate binding between HoxB1 and Pbx1 and a hexapeptide consensus sequence (Nalpha-acetyl-Leu-Phe-Pro-Trp-Met-Arg-amide). The consensus peptide exists in two conformations caused by cis-trans isomerization of the Phe-Pro peptide bond. The structures of the HoxB1 peptide and the trans form of the consensus peptide reveal a turn very similar to that found as part of the HoxB1/Pbx1/DNA complex in the X-ray crystal structure. This observation implies that this region is at least partially 'preformed' and thus ready to interact with Pbx1 and stabilize binding of Pbx1 and HoxB1 to DNA. The structural results presented here provide a starting point for synthesizing potential nonpeptide or cyclical peptide antagonists that mimic the interaction of these transcriptional cofactors resulting in a potential chemotherapeutic for certain types of leukemias.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369863      PMCID: PMC2374006          DOI: 10.1110/ps.50901

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  32 in total

1.  The 'dynamics' in the thermodynamics of binding.

Authors:  J D Forman-Kay
Journal:  Nat Struct Biol       Date:  1999-12

2.  Structural basis of Hox specificity.

Authors:  D S Wilson; C Desplan
Journal:  Nat Struct Biol       Date:  1999-04

Review 3.  Homeobox genes and axial patterning.

Authors:  W McGinnis; R Krumlauf
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

Review 4.  Extra specificity from extradenticle: the partnership between HOX and PBX/EXD homeodomain proteins.

Authors:  R S Mann; S K Chan
Journal:  Trends Genet       Date:  1996-07       Impact factor: 11.639

5.  extradenticle raises the DNA binding specificity of homeotic selector gene products.

Authors:  M A van Dijk; C Murre
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

Review 6.  Homeodomain proteins.

Authors:  W J Gehring; M Affolter; T Bürglin
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

7.  A novel homeobox protein which recognizes a TGT core and functionally interferes with a retinoid-responsive motif.

Authors:  E Bertolino; B Reimund; D Wildt-Perinic; R G Clerc
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

8.  The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9.

Authors:  J Borrow; A M Shearman; V P Stanton; R Becher; T Collins; A J Williams; I Dubé; F Katz; Y L Kwong; C Morris; K Ohyashiki; K Toyama; J Rowley; D E Housman
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

9.  'Random coil' 1H chemical shifts obtained as a function of temperature and trifluoroethanol concentration for the peptide series GGXGG.

Authors:  G Merutka; H J Dyson; P E Wright
Journal:  J Biomol NMR       Date:  1995-01       Impact factor: 2.835

10.  A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL.

Authors:  M P Kamps; C Murre; X H Sun; D Baltimore
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

View more
  8 in total

1.  Cooperative DNA-binding and sequence-recognition mechanism of aristaless and clawless.

Authors:  Ken-ichi Miyazono; Yuehua Zhi; Yuriko Takamura; Koji Nagata; Kaoru Saigo; Tetsuya Kojima; Masaru Tanokura
Journal:  EMBO J       Date:  2010-04-13       Impact factor: 11.598

Review 2.  Biophysical characterization of G-protein coupled receptor-peptide ligand binding.

Authors:  David N Langelaan; Pascaline Ngweniform; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2011-04       Impact factor: 3.626

3.  Immunocytochemical detection of HoxD9 and Pbx1 homeodomain protein expression in Chinese esophageal squamous cell carcinomas.

Authors:  De-Bin Liu; Zhen-Dong Gu; Xiao-Zhe Cao; Hong Liu; Ji-You Li
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

4.  Temperature-sensitive protein-DNA dimerizers.

Authors:  Karl E Hauschild; Renee E Metzler; Hans-Dieter Arndt; Rocco Moretti; Marni Raffaelle; Peter B Dervan; Aseem Z Ansari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

Review 5.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

6.  The intrinsically disordered regions of the Drosophila melanogaster Hox protein ultrabithorax select interacting proteins based on partner topology.

Authors:  Hao-Ching Hsiao; Kim L Gonzalez; Daniel J Catanese; Kristopher E Jordy; Kathleen S Matthews; Sarah E Bondos
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

7.  Atomistic molecular dynamics simulations of bioactive engrailed 1 interference peptides (EN1-iPeps).

Authors:  Neha S Gandhi; Pilar Blancafort; Ricardo L Mancera
Journal:  Oncotarget       Date:  2018-04-27

8.  HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.

Authors:  Liang Han; Dehua Liu; Zhaohui Li; Nan Tian; Ziwu Han; Guang Wang; Yao Fu; Zhigang Guo; Zifeng Zhu; Chao Du; Yu Tian
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.